Case
Smartius advised Surgify in its EUR 7 million funding round
Smartius advised Surgify Medical Oy in their latest EUR 7 million funding round for expanding its operations in Europe and the U.S. with its unique bone-cutting technology that protects soft tissue in head, neck, and spine procedures. The funding round was led by ZEISS Ventures, the corporate venture arm of the Carl ZEISS Group, with participation from the EIC – European Innovation Council (EIC Fund). Surgify’s existing investors, including Lednil AB and Cascara Ventures, also participated in the financing.
Smartius team comprised Simo Kaartinen, Sara Aho, and Antto Toivio.